Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
1.230
-0.030 (-2.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Talphera Revenue
Talphera had revenue of $1,000.00 in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $28.00K, down -90.04% year-over-year.
Revenue (ttm)
$28.00K
Revenue Growth
-90.04%
P/S Ratio
2,047.49
Revenue / Employee
$2,154
Employees
13
Market Cap
57.33M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLPH News
- 23 days ago - Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 weeks ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire
- 6 weeks ago - Talphera Announces the Appointment of Joe Todisco to Board of Directors - PRNewsWire
- 3 months ago - CorMedix Announces Strategic Minority Investment in Talphera - GlobeNewsWire
- 3 months ago - Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market - PRNewsWire
- 3 months ago - Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial - PRNewsWire
- 4 months ago - Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript - Seeking Alpha